Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia.

Saved in:
Bibliographic Details
Title: Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia.
Authors: Goede V; Department of Oncogeriatrics, St. Marien Hospital, Cologne, Germany., Fischer K; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Robrecht S; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Giza A; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom., Eckart MJ; Oncology Practice, Erlangen, Germany., Mϋller L; Oncology Practice, Leer, Germany., Smolej L; 4th Department of Internal Medicine - Haematology, Charles University Faculty of Medicine, University Hospital, Hradec Králové, Czech Republic., Kutsch N; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Fink AM; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Hallek M; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.; Cologne Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
Source: Blood advances [Blood Adv] 2025 May 27; Vol. 9 (10), pp. 2431-2435.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2024014875